Evidence map›Paper›PMID 25141238›Full record

ArticlePloS one2014

Proteomic characterization of Helicobacter pylori CagA antigen recognized by child serum antibodies and its epitope mapping by peptide array.

Junko Akada, Masumi Okuda, Narumi Hiramoto, Takao Kitagawa, Xiulian Zhang, Shuichi Kamei, Akane Ito, Mikiko Nakamura, Tomohisa Uchida, Tomoko Hiwatani and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Molecular mimicry inWorld journal of gastroenterology · 2017
    Review
  6. Novel CagA ELISA exhibits enhanced sensitivity ofWorld journal of gastroenterology · 2017
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Junko AkadaDepartment of Biochemistry and Functional Proteomics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
Masumi OkudaSasayama Medical Center, Hyogo College of Medicine, Sasayama, Hyogo, Japan; Department of General Medicine and Community Health Science, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
Narumi HiramotoDepartment of Biochemistry and Functional Proteomics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
Takao KitagawaDepartment of Biochemistry and Functional Proteomics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
Xiulian ZhangDepartment of Biochemistry and Functional Proteomics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
Shuichi KameiTechnical Research Laboratory, Toyo Kohan Company, Ltd., Kudamatsu, Yamaguchi, Japan.
Akane ItoTechnical Research Laboratory, Toyo Kohan Company, Ltd., Kudamatsu, Yamaguchi, Japan.
Mikiko NakamuraInnovation Center with University-Industry-Public Cooperation, Organization for Research Initiatives, Yamaguchi University, Tokiwadai, Ube, Yamaguchi, Japan.
Tomohisa UchidaDepartment of Molecular Pathology, Oita University, Faculty of Medicine, Oita University, Yufu, Oita, Japan.
Tomoko HiwataniWakayama-Rosai Hospital, Wakayama, Wakayama, Japan.
Yoshihiro FukudaSasayama Medical Center, Hyogo College of Medicine, Sasayama, Hyogo, Japan; Department of General Medicine and Community Health Science, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
Teruko NakazawaDepartment of Microbiology and Immunology, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
Yasuhiro KuramitsuDepartment of Biochemistry and Functional Proteomics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
Kazuyuki NakamuraDepartment of Biochemistry and Functional Proteomics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
Yamaguchi University · JPHyogo Medical University · JPToyo Kohan (Japan) · JPOita University · JPWakayama Rosai Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serum antibodies against pathogenic bacteria play immunologically protective roles, and can be utilized as diagnostic markers of infection. This study focused on Japanese child serum antibodies against Helicobacter pylori, a chronically-infected gastric bacterium which causes gastric cancer in adults. Serological diagnosis for H. pylori infection is well established for adults, but it needs to be improved for children. Serum samples from 24 children, 22 H. pylori (Hp)-positive and 2 Hp-negative children, were used to catalogue antigenic proteins of a Japanese strain CPY2052 by two-dimensional electrophoresis followed by immunoblot and LC-MS/MS analysis. In total, 24 proteins were identified as candidate antigen proteins. Among these, the major virulence factor, cytotoxin-associated gene A protein (CagA) was the most reactive antigen recognized by all the Hp-positive sera even from children under the age of 3 years. The major antigenic part of CagA was identified in the middle region, and two peptides containing CagA epitopes were identified using a newly developed peptide/protein-combined array chip method, modified from our previous protein chip method. Each of the epitopes was found to contain amino acid residue(s) unique to East Asian CagA. Epitope analysis of CagA indicated importance of the regional CagA antigens for serodiagnosis of H. pylori infection in children.

Indexed as

Antigens, BacterialBacterial ProteinsChildChild, PreschoolEpitope MappingHelicobacter InfectionsHelicobacter pyloriHumansProteomicsAntigens, BacterialBacterial ProteinscagA protein, Helicobacter pylori

Identifiers

PMID25141238
PMCPMC4139317
OpenAlexW2072996016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.